Vanda Repiská

1.3k total citations
73 papers, 899 citations indexed

About

Vanda Repiská is a scholar working on Molecular Biology, Cancer Research and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Vanda Repiská has authored 73 papers receiving a total of 899 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 22 papers in Cancer Research and 15 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Vanda Repiská's work include Cancer Genomics and Diagnostics (11 papers), Gestational Trophoblastic Disease Studies (10 papers) and Prenatal Screening and Diagnostics (10 papers). Vanda Repiská is often cited by papers focused on Cancer Genomics and Diagnostics (11 papers), Gestational Trophoblastic Disease Studies (10 papers) and Prenatal Screening and Diagnostics (10 papers). Vanda Repiská collaborates with scholars based in Slovakia, Singapore and Czechia. Vanda Repiská's co-authors include Č Altaner, Ursula Altanerova, Jana Jakubechova, Gabriel Minárik, Peter Stanko, Helena Gbelcová, Veronika Altanerová, Peter Babinec, Melánia Babincová and Ľ Danihel and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and International Journal of Cancer.

In The Last Decade

Vanda Repiská

64 papers receiving 892 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vanda Repiská Slovakia 15 488 260 117 114 103 73 899
Seiji Kojima Japan 20 308 0.6× 92 0.4× 213 1.8× 175 1.5× 122 1.2× 40 1.1k
Jocelyn Weiss Australia 15 596 1.2× 385 1.5× 101 0.9× 43 0.4× 66 0.6× 17 953
Pierre Teira Canada 14 205 0.4× 74 0.3× 214 1.8× 222 1.9× 80 0.8× 43 725
Renee M. McGovern United States 22 693 1.4× 304 1.2× 534 4.6× 96 0.8× 129 1.3× 50 1.5k
Kaoru Yamawaki Japan 12 373 0.8× 289 1.1× 338 2.9× 33 0.3× 71 0.7× 27 1.1k
Anna Andersson Sweden 26 731 1.5× 210 0.8× 205 1.8× 160 1.4× 176 1.7× 55 1.8k
Alireza Biglari Iran 13 376 0.8× 173 0.7× 115 1.0× 86 0.8× 99 1.0× 50 667
Hisham Abdel‐Azim United States 17 294 0.6× 51 0.2× 275 2.4× 157 1.4× 92 0.9× 68 966
Anne Talvensaari‐Mattila Finland 20 474 1.0× 805 3.1× 615 5.3× 50 0.4× 109 1.1× 60 1.4k
Tülin Budak-Alpdoǧan United States 18 430 0.9× 74 0.3× 310 2.6× 105 0.9× 149 1.4× 51 970

Countries citing papers authored by Vanda Repiská

Since Specialization
Citations

This map shows the geographic impact of Vanda Repiská's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanda Repiská with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanda Repiská more than expected).

Fields of papers citing papers by Vanda Repiská

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanda Repiská. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanda Repiská. The network helps show where Vanda Repiská may publish in the future.

Co-authorship network of co-authors of Vanda Repiská

This figure shows the co-authorship network connecting the top 25 collaborators of Vanda Repiská. A scholar is included among the top collaborators of Vanda Repiská based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanda Repiská. Vanda Repiská is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Repiská, Vanda, et al.. (2025). Multiple Loss of Heterozygosity in a Case of Rare Ovarian Mixed Germ Cell Tumor - Case Report and Overview of Literature. Bratislavské lekárske listy/Bratislava medical journal. 126(1). 34–40.
2.
Pastorakova, Andrea, et al.. (2024). Small extracellular vesicles derived from mesenchymal stem/stromal cells as drug-delivery tools for anti-cancer drugs. Journal of Drug Delivery Science and Technology. 99. 105999–105999. 1 indexed citations
3.
4.
Krumpolec, Patrik, Péter Baráth, Marian Grendár, et al.. (2023). The Potential of Liquid Biopsy in Detection of Endometrial Cancer Biomarkers: A Pilot Study. International Journal of Molecular Sciences. 24(9). 7811–7811. 2 indexed citations
5.
Pös, Ondrej, et al.. (2023). Cross-Kingdom Interaction of miRNAs and Gut Microbiota with Non-Invasive Diagnostic and Therapeutic Implications in Colorectal Cancer. International Journal of Molecular Sciences. 24(13). 10520–10520. 3 indexed citations
6.
Svoboda, M., et al.. (2023). Comprehensive Genomic Profiling in Predictive Testing of Cancer. Physiological Research. 72(S3). S267–S275. 3 indexed citations
7.
Pös, Zuzana, Ondrej Pös, Ján Radvánszky, et al.. (2023). Microsatellite instability assessment is instrumental for Predictive, Preventive and Personalised Medicine: status quo and outlook. The EPMA Journal. 14(1). 143–165. 11 indexed citations
8.
Repiská, Vanda, et al.. (2023). Double Trisomy 16 and 22 Clinically Mimic Partial Hydatidiform Mole in a Case of Subsequent Pregnancy Loss. Physiological Research. 72(S3). S309–S313.
9.
Pastorek, Michal, Július Hodosy, Katarı́na Šebeková, et al.. (2023). Mitochondrial DNA variability and Covid-19 in the Slovak population. Mitochondrion. 75. 101827–101827. 5 indexed citations
10.
Buglyó, Gergely, Ondrej Pös, Beáta Soltész, et al.. (2022). Extracellular Nucleic Acids in the Diagnosis and Progression of Colorectal Cancer. Cancers. 14(15). 3712–3712. 6 indexed citations
11.
Buglyó, Gergely, Ondrej Pös, Vanda Repiská, et al.. (2022). Liquid Biopsy as a Source of Nucleic Acid Biomarkers in the Diagnosis and Management of Lynch Syndrome. International Journal of Molecular Sciences. 23(8). 4284–4284. 10 indexed citations
12.
Machala, Zdenko, et al.. (2021). Selective Apoptotic Effect of Plasma Activated Liquids on Human Cancer Cell Lines. Molecules. 26(14). 4254–4254. 24 indexed citations
13.
Viktorová, Jitka, et al.. (2021). Peptaibol-Containing Extracts of Trichoderma atroviride and the Fight against Resistant Microorganisms and Cancer Cells. Molecules. 26(19). 6025–6025. 14 indexed citations
14.
Matáková, Tatiana, et al.. (2020). Methylation of MMP2, TIMP2, MMP9 and TIMP1 in abdominal aortic aneurysm. Bratislavské lekárske listy/Bratislava medical journal. 121(10). 717–721. 2 indexed citations
15.
Gbelcová, Helena, Silvie Rimpelová, Zdeněk Knejzlı́k, et al.. (2017). Isoprenoids responsible for protein prenylation modulate the biological effects of statins on pancreatic cancer cells. Lipids in Health and Disease. 16(1). 250–250. 28 indexed citations
16.
Lipov, Jan, et al.. (2016). ERVW-1 gene polymorphisms related to preeclampsia. Bratislavské lekárske listy/Bratislava medical journal. 117(6). 340–344. 2 indexed citations
17.
18.
Varga, Ivan, et al.. (2011). INCIDENCE OF MICRODELETIONS IN THE AZF REGION OF THE Y CHROMOSOME IN SLOVAK PATIENTS WITH AZOOSPERMIA. Biomedical Papers. 155(1). 33–38. 26 indexed citations
19.
Repiská, Vanda, et al.. (2010). ESTABLISHMENT OF PARAOXONASE AND ARYLESTERASE ACTIVITY OF PARAOXONASE 1 (PON1) IN DEPENDENCE ON 55(L/M) AND 192(Q/R) DNA POLYMORPHISM IN ADULT PEOPLE WITH DOWN SYNDROME. SHILAP Revista de lepidopterología. 1 indexed citations
20.
Wang, Chiuhui Mary, Peter Dixon, Matt Hodges, et al.. (2009). Identification of 13 novel NLRP7 mutations in 20 families with recurrent hydatidiform mole; missense mutations cluster in the leucine-rich region. Journal of Medical Genetics. 46(8). 569–575. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seiji Kojima Breakdown of academic impact, for papers by Jocelyn Weiss Breakdown of academic impact, for papers by Pierre Teira Breakdown of academic impact, for papers by Renee M. McGovern Breakdown of academic impact, for papers by Kaoru Yamawaki Breakdown of academic impact, for papers by Anna Andersson Breakdown of academic impact, for papers by Alireza Biglari Breakdown of academic impact, for papers by Hisham Abdel‐Azim Breakdown of academic impact, for papers by Anne Talvensaari‐Mattila Breakdown of academic impact, for papers by Tülin Budak-Alpdoǧan
Rankless by CCL
2026